# Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis

> **NCT00956254** · PHASE3 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 18 (actual)

## Conditions studied

- Mucositis
- Pain
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Fentanyl sublingual spray

## Key facts

- **NCT ID:** NCT00956254
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956254, "Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00956254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*